Back to 
Assenagon Asset Management S.A.
Assenagon Asset Management S.A.
CLDXShowing 5 of 7 quarters
Position history for Assenagon Asset Management S.A.'s holdings in CELLDEX THERAPEUTICS INC NEW
Yes. Assenagon Asset Management holds 444,922 shares of CLDX (Celldex Therapeutics), worth $14.4M, as of its Q3 2026 13F filing. It reduced the position by 343,774 shares (-43.6%) from Q2 2026. Assenagon Asset Management has held CLDX since Q1 2026, across 3 quarterly 13F filings.
Current Value
$14.4M
Current Shares
444,922
Total Value Change
+$13.7M
Total Shares Change
+423,976
Quarter-by-Quarter History
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP